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An acute increase in blood flow triggers flow-mediated dilation (FMD), which is mainly mediated by 
endothelial nitric oxide synthase (eNOS). A long-term increase in blood flow chronically enlarges the 
arterial lumen, a process called arteriogenesis. In several common human diseases, these processes are 
disrupted for as yet unknown reasons. Here, we asked whether β1 integrin, a mechanosensory protein 
in endothelial cells, is required for FMD and arteriogenesis in the ischemic hindlimb. Permanent ligation 
of the femoral artery in C57BL/6 J mice enlarged pre-existing collateral arteries and increased numbers 
of arterioles in the thigh. In the lower leg, the numbers of capillaries increased. Notably, injection of β1 
integrin-blocking antibody or tamoxifen-induced endothelial cell-specific deletion of the gene for β1 
integrin (Itgb1) inhibited both arteriogenesis and angiogenesis. Using high frequency ultrasound, we 
demonstrated that β1 integrin-blocking antibody or endothelial cell-specific depletion of β1 integrin 
attenuated FMD of the femoral artery, and blocking of β1 integrin function did not further decrease 
FMD in eNOS-deficient mice. Our data suggest that endothelial β1 integrin is required for both acute 
and chronic widening of the arterial lumen in response to hindlimb ischemia, potentially via functional 
interaction with eNOS.
Arteries can adapt to changes in blood flow and the vascular endothelium is crucially involved in the fundamental 
regulation of blood flow to ensure the matching of demand and supply of tissues with oxygen and nutrients. For 
example, after transient ischemia and during situations of increased oxygen and nutrient demand (e.g., during 
physical exercise), arterial blood flow increases1. As a response to increased shear forces during reactive hyper-
emia, healthy arteries dilate in the presence of oxygen primarily via release of nitric oxide (NO), a process called 
flow-mediated vasodilation (FMD)2. Long-term increases in blood flow result in a structural enlargement of the 
arterial lumen. It is known for a long time that endurance training leads to enlargement of femoral arteries in 
athletes3. While the mechanisms are unknown, this structural adaptation involves the outward remodelling along 
with proliferation of endothelial cells and vascular smooth muscle cells (SMC), monocyte recruitment, and extra-
cellular matrix turnover4. The latter processes result in larger vascular lumens and increased numbers of arterioles 
and capillaries1, allowing more blood to flow through the skeletal muscles of the limbs, thus alleviating hypoxia in 
situations of increased demand for oxygen and nutrients1.
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In the setting of ischemic diseases, an occlusion of a major feed artery results in downstream dilation of 
resistance arteries, leading to rerouting of blood flow through pre-existing collateral arteries. In response to the 
increase in blood flow and shear stress, the collateral arteries dilate (acute response), and, after several days, start 
to show signs of structural remodelling; this process is referred to as ‘arteriogenesis4–6. Two distinct types of 
adult arteriogenesis exist that result in restoration of blood flow towards the compromised hypo-perfused tissue; 
that is (i) the enlargement of pre-existing collateral arteries (or classical arteriogenesis) and (ii) the process of 
arterialization of capillaries (or de novo arteriogenesis)4,7. Remodelling of pre-existing collaterals involves shear 
stress-dependent activation of endothelial nitric oxide synthase (eNOS), leading to their acute vasodilation6,8–11. 
Vasodilation, in turn, increases circumferential wall stress which then promotes growth and enlargement of the 
media layer which is supported by recruited monocytes4,12. Mechanical stress induces smooth muscle cell prolif-
eration involving a switch in cellular phenotype from a contractile to a proliferative one. The critical role of NO is 
demonstrated by a markedly lowered arteriogenesis and vessel rarefaction in eNOS (or Nos3)-deficient mice13,14. 
In contrast, de novo arteriogenesis is due to capillary arterialization15. It is a poorly understood process that is 
believed to be largely driven by endothelial cells16, involves change in endothelial cell (EC) fate, and acquisition of 
a medial layer4. Besides arteriogenesis taking place in upstream regions of the ischemic hindlimb, which are less 
exposed to prolonged hypoxia, more distal regions show increased angiogenesis, a process driven by local skeletal 
muscle hypoxia activating the HIF-1α-VEGF-A pathway (independent of shear stress)17.
How an increased shear stress is sensed is not fully understood, but VE-Cadherin and VEGF receptor-2 as 
well as Klf2 play critical roles18,19. Furthermore, another possible mechanosensory protein on EC could be β1 inte-
grin, a membrane-anchored subunit of many integrins20,21. Loss- and gain-of-function studies have shown that 
endothelial β1 integrin is involved in vascular lumen formation of arteries, angiogenesis, inflammatory processes, 
and vessel wall remodelling22–24. β1 integrin appears to be essential for blood vessel formation during embryonic 
development as well as for postnatal vascular remodelling, smooth muscle vasomotor control, and wound heal-
ing22–24. Furthermore, it regulates endothelial cell polarity and arteriolar lumen formation25. More recent litera-
ture showed that endothelial β1 integrin is required for the formation of stable, non-leaky blood vessels and has 
an acute function in vessel growth and maturation26. While homozygous deletion of Itgb1 is embryonically lethal, 
mice with a heterozygous endothelial cell-specific deletion showed abnormal vascular remodelling in response 
to changed blood flow after external carotid artery ligation23. In a rabbit hindlimb ischemia model, it was also 
demonstrated that α5β1 integrin was upregulated after increases in fluid shear stress in collaterals27. A recent in 
vitro study suggests that β1 integrin may not only function in EC via interactions with components of basement 
membrane, but that it may also trigger shear stress-mediated activation of eNOS at the apical EC surface28. Here, 
we provide evidence that β1 integrin plays an important role in both FMD and arteriogenesis in the thigh during 
hindlimb ischemia (HI).
Results
Blocking β1 integrin function abrogates arteriogenesis and angiogenesis. To study whether β1 
integrin plays a role in arteriogenesis under conditions of chronically increased collateral blood flow, we induced 
HI by total ligation of the femoral artery (FA) in WT mice treated with and without β1 integrin blocking antibod-
ies as well as in gene-deficient mice (Supplementary Fig. S1). While the HI led to significantly decreased perfusion 
of the thigh and calf, the thigh recovered to baseline perfusion within 3 days, while it remained decreased in the 
calf (Supplementary Fig. S2). Furthermore, endothelial β1 integrin expression increased in the calf, while only 
showing a small trend towards higher expression in the thigh (Supplementary Fig. S3), consistent with a previous 
report showing that hypoxia via HIF-1α can induce β1 integrin expression29. Two groups of WT animals received 
either β1 integrin blocking antibodies or isotype-matched control antibodies (Supplementary Fig. S1a). In the 
control group, native collateral diameter was increased at day 7 post-ligation as compared to sham-operated/
unligated animals (Fig. 1a–e). Integrin antibody treatment significantly inhibited this collateral diameter increase 
(Fig. 1e), suggesting a functional role for β1 integrin.
Furthermore, FA ligation led to differential microvascular adaptations in the thigh (Fig. 1f–k) compared to 
the calf (Fig. 1l–q). In the thigh muscles, we observed a higher number of arterioles consistent with de novo 
arteriogenesis (Fig. 1j). In contrast, the number of capillaries was unchanged (Fig. 1k). Conversely, in the calf, we 
observed a greater number of capillaries but not arterioles (Fig. 1p,q). Since β1 integrin blockade inhibited both 
the increase in arterioles in the thigh and capillaries in the calf, β1 integrin function is needed for both arterio-
genesis and angiogenesis induced by HI.
Endothelium-specific knockout of Itgb1 abrogates arteriogenesis and angiogenesis. To sub-
stantiate our findings on β1 integrin, we next conducted HI experiments in endothelium-specific Itgb1 knockout 
mice, Itgb1iECKO (Fig. 2), with the Cdh5 promoter as an endothelium-specific driver. Cdh5-CreERT2 mice were 
used as Cre controls, and both mouse lines were treated equally with tamoxifen injections (see Supplementary 
Fig. S4 for knockout efficiency). Induction of knockout by tamoxifen injection affected neither the number of 
arterioles and capillaries nor EC viability (Fig. 2, Supplementary Fig. S5 and S6). Notably, Cre control mice exhib-
ited de novo arteriogenesis (Fig. 2e,k), whereas Itgb1iECKO mice did not show any increase in the number of arte-
rioles (Fig. 2e,k).
Furthermore, angiogenesis in the calf appeared to be absent in Itgb1iECKO as indicated by lack of increase in 
capillary density upon HI (Fig. 2l). Finally, the number of capillaries in the thigh 7d post-HI (Fig. 2f) was unaf-
fected by the endothelial cell-specific deletion of Itgb1 (Fig. 2f). Taken together, these genetic data and results 
with β1 integrin blocking antibodies suggest that endothelial β1 integrin is required for both arteriogenesis and 
angiogenesis after HI.
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Requirement of β1 integrin for flow-mediated dilation (FMD). To study whether β1 integrin is 
required for FMD, we measured FMD in conduit arteries of living rodents in a manner that is similar to FMD 
measurements in humans2,30. More specifically in this model, 5 min of lower leg occlusion are used to induce 
vasodilation of resistance arteries after reperfusion, which in turn increased blood flow and FMD in the upstream 
FA. Blood flow velocity and FMD were measured in the FA of C57BL/6 J WT mice injected with either β1 integrin 
blocking antibody or isotype-matched control antibody (Fig. 3; for set-up and basic physiology, see Fig. 3a–e; 
see Supplementary Fig. S7 for blocking antibody dose-response). The increase in flow velocity in response to 
acute ischemia remained largely unaffected by either antibody treatment (Fig. 3f,g), indicating that the degree of 
resistance artery dilation and hence the stimulus for FMD – shear stress – was not substantially affected by the 
antibodies. Notably, we found that the β1 integrin blockade inhibited FMD, whereas the control antibody had no 
effect (Fig. 3h,i). In addition, Itgb1iECKO mice with tamoxifen-induced endothelium-specific Itgb1 knockout did 
not differ from Cre controls with regard to the flow velocity response to ischemia (Fig. 4a,b). However, Itgb1iECKO 
mice exhibited a strongly decreased FMD response (Fig. 4c,d). In summary, the results show that β1 integrin in 
general and especially in endothelial cells is strictly required for FMD response following an acute HI.
Potential interaction between β1 integrin and eNOS in flow-mediated dilation (FMD). To 
investigate the role of eNOS as a potential downstream effector of β1 integrin (Fig. 3f–i), we performed FMD 
measurements in mice deficient for Nos3, the gene coding for eNOS. The mice were injected with either β1 inte-
grin blocking antibody or isotype-control antibody. While FMD was lower in Nos3 knockout mice as compared 
to WT mice, β1 integrin blocking had no further effect on FMD in these Nos3-deficient mice. With regard to 
its subcellular localization, immunohistochemical stainings showed that in EC β1 integrin was not exclusively 
expressed at the basolateral side, but also present on the luminal side (Supplementary Fig. S8). Finally, knock-
down of β1 integrin in human arterial endothelial cells reduced expression levels of total and phosphorylated 
eNOS (Supplementary Fig. S9 and S10 for uncropped Western blots), further indicating a functional interaction 
between β1 integrin and eNOS.
Figure 1. Attenuation of de novo arteriogenesis in the thigh and angiogenesis in the calf by β1 integrin blocking 
antibodies following femoral artery ligation. (a–e) Collateral expansion as observed 7 days after femoral artery 
(FA) ligation. (a) Schematic drawing of experimental setup. (b–d) Brightfield microscopic image of the thigh, FA 
was perfused with Pu4 resin (blue): (b) thigh of sham operated mice, (c) mice after 7 days of hindlimb ischemia 
(HI) treated with control antibody (HI + ctrl-AB), and (d) β1 integrin blocking antibodies (HI + β1-B-AB). (e) 
Quantification of the collateral diameters after 7 days of HI in sham operated mice (n = 5), mice treated with 
ctrl-AB (n = 8) or β1-B-AB (n = 9). (f–k) Analysis of de novo arteriogenesis and angiogenesis, in thigh muscles 7 
days after HI. (f) Schematic drawing of experimental setup. (g–i) Fluorescence microscopy images of arterioles 
and capillaries in thigh muscle stained for cell nuclei (DAPI, blue), endothelial cells (PECAM-1, red) and smooth 
muscle cells (α-SMA, green) in (g) sham operated animals (n = 5), (h) mice after 7 days HI with ctrl-AB (n = 5), 
and (i) β1-B-AB (n = 5). (j + k) Quantification of (j) arterioles per mm2 and (k) capillaries per muscle fibre. (l–q) 
Analysis of de novo arteriogenesis and angiogenesis in calf muscles 14 days after HI. (l) Schematic drawing of 
experimental setup. (m–o) Fluorescence microscopy images of arterioles and capillaries in calf muscle stained 
for cell nuclei (DAPI, blue), endothelial cells (PECAM-1, red) and smooth muscle cells (α-SMA, green) in (m) 
sham operated mice (n = 5), (n) mice after 14 days HI with ctrl-AB (n = 6), and (o) β1-B-AB (n = 5). (p + q) 
Quantification of (p) arterioles per mm2 and (q) capillaries per muscle fibre. All values are mean ± standard error of 
the mean (SEM), statistical significance was determined using one-way ANOVA with Tukey post-hoc test, *p ≤ 0.05.
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Discussion
Our present data show that endothelial β1 integrin is required for induction of FMD in response to acute 
increases in blood flow and for arteriogenesis caused by chronically increased blood flow after FA ligation. Our 
data are based on both antibody blocking and genetic knockout experiments in combination with physiological 
and morphometric measurements.
In humans, impairments in FMD have been linked to cardiovascular disease development and adverse out-
come31. While a central role of eNOS is firmly established31, the mechanisms of how changes in blood flow are 
sensed is less clear4,6. Our current data show that endothelial β1 integrin is required for induction of FMD in 
response to acute increases in blood flow. Previous research has already indicated that integrins are involved 
in vasodilation in experimental models (i.e., murine mesenteric resistance arteries and porcine coronary arte-
rioles)32,33. For instance, in isolated mesenteric resistance arteries in vitro α1 integrin played an important role 
in FMD through activation of phosphoinositide 3-kinase (PI3K) and Akt serine/threonine kinases32. In isolated 
porcine arterioles, it was shown that activation of endothelial αvβ3 and α5β1 integrins mediated coronary arteri-
olar dilation via the endothelial production of cyclooxygenase-derived prostaglandins34, a pathway that seems to 
be less relevant in peripheral artery FMD in humans and rodents2,30. In another study, also using isolated porcine 
arterioles, it was observed that abluminally located β3 integrin was involved in FMD using a blocking antibody 
while it was unaffected by a macromolecular complex of inhibitors that remained intraluminal33. In contrast, a 
more recent in vitro study on bovine aortic endothelial cells suggested that apically expressed β1 integrin was rap-
idly activated in response to acute shear stress28. In these EC, the blockade of β1 integrin activation attenuated a 
shear-induced signalling cascade involving Src-family kinase, PI3K, Akt, and eNOS on the apical endothelial cell 
surface27. Furthermore, Xanthis et al. recently showed that β1 integrin was a key sensor of unidirectional shearing 
forces using in vitro flow systems and magnetic tweezers on apical β1 integrin in human umbilical vein endothe-
lial cells (HUVEC)35. The authors also observed that β1 integrin knockout inhibited both acute Ca2+ responses 
and eNOS expression increases due to shear stress. Using super-resolution microscopy, they showed that activa-
tion of luminal/apical β1 integrin but not basolateral β1 integrin in mouse aorta endothelial cells correlated with 
shear responses in vivo. While these data show that apical β1 integrin can respond to force, they do not preclude 
the important and well-established role for basally located integrins. Our current data support that β1 integrin is 
expressed at the apical and basolateral sides in ECs. As both sides may contribute to flow sensing, the mechanisms 
how endothelial cells integrate microenvironmental downstream signals from apical and basal β1 integrin need 
to be further investigated35. To date, due to a previous lack of a methodology to measure FMD in vivo in mice2, 
the role of endothelial β1 integrin in clinically relevant FMD have not yet been investigated. Our data show that 
FMD is significantly and dose-dependently inhibited by β1 integrin blocking antibodies and endothelial specific 
knockout of β1 integrin. Furthermore, we show that this effect was similar to NOS3 knockout animals in which β1 
integrin blocking did not further inhibit FMD. Furthermore, our in vitro data indicate that β1 integrin contributes 
to eNOS expression and activation.
Figure 2. Inhibition of de novo arteriogenesis in the thigh and angiogenesis in the calf by endothelium-specific 
Itgb1 KO mice following femoral artery ligation. (a–d) Fluorescence microscopy images of arterioles and 
capillaries in the thigh muscle stained for cell nuclei (DAPI, blue), endothelial cells (PECAM-1, red) and smooth 
muscle cells (α-SMA, green) in (a) sham operated Cre controls (n = 6), (b) sham operated Itgb1iECKO mice (n = 6), 
(c) Cre controls after 7 days HI (n = 6) and (d) Itgb1iECKO mice after 7 days HI (n = 6). (e + f) Quantification of 
(e) arterioles per mm2 and (f) capillaries per fibre. (g–j) Fluorescence microscopy images of capillaries in the calf 
muscles stained for cell nuclei (DAPI, blue), endothelial cells (PECAM-1, red) in (g) sham operated Cre controls 
(n = 6), (h) sham operated Itgb1iECKO mice (n = 6), (i) Cre controls after 14 days HI (n = 6), and (j) Itgb1iECKO mice 
after 14 days HI (n = 6). (k + l) Quantification of (k) arterioles per mm2 and (l) capillaries per fibre. All values 
are mean ± standard error of the mean (SEM), statistical significance was determined using two-way ANOVA with 
Tukey post-hoc test, *p ≤ 0.05.
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Figure 3. Inhibition of flow-mediated vasodilation in the femoral artery by β1 integrin blocking in mice with 
and without endothelial nitric oxide synthase (eNOS). (a) Experimental setup of flow-mediated dilation (FMD) 
measurements: see2 for details. (b) Longitudinal B-mode ultrasound image of FA and (c) zoomed image with 
automatic edge detection. (d) Original Doppler flow velocity in FA at baseline. (e) Exemplary flow velocity, wall 
shear stress (WSS), and vessel diameter during reperfusion after response to 5 min ischemia in WT mice. (f + g) 
Flow velocity (f) over the first 180 s or (g) at 0 s during reperfusion after 5 min ischemia in WT (untreated and 
treated mice with ctrl-AB or β1−Β−ΑΒ) and endothelial nitric oxide synthase (eNOS) knockout (NOS3−/−) 
mice (treated with ctrl-AB or β1−Β−ΑΒ) (n = 3, per group). (h + i) Quantification of FMD (h) over the first 
180 s or (j) at 60 s during reperfusion after 5 min ischemia in WT (untreated, treated with ctrl-AB or β1−Β−ΑΒ)  
and NOS3−/− mice (treated with ctrl-AB or β1−Β−ΑΒ) (n = 3, per group). All values are mean ± standard 
error of the mean (SEM), statistical significance was determined using one-way ANOVA with Tukey post-hoc test, 
*p ≤ 0.05. No statistical significances are shown in (e)(f)(h).
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As a response to ischemia, changes in blood flow lead to acute vasodilation and chronically to vascular remod-
elling processes, such as angiogenesis and arteriogenesis. While it was previously shown that β1 integrin was 
upregulated in collaterals during arteriogenesis27, it was unknown if β1 integrin was required for collateral growth 
in the hindlimb. Others have shown using α5 integrin-targeted microbubbles in a murine iliac occlusion hind-
limb model that a signal enhancement from α5 integrin coincides with early blood flow recovery in the adductor 
muscles36. Furthermore, β1 integrin expression was shown to be upregulated in response to hypoxia via activation 
of the transcription factor HIF-1α in fibroblasts during wound healing29. Our current data integrate with these 
previous findings and provide evidence for the essential role of endothelial β1 integrin during HI-induced arteri-
ogenesis in mice. Notably, endothelium-specific deletion of the integrin does not induce EC-apoptosis, indicating 
that the observed effects are not due to changed EC-viability in general. However, further work is needed to 
uncover the full molecular mechanisms by which β1 integrin in EC contributes to FMD, arteriogenesis, and angi-
ogenesis. Detection of differences in formation of heterodimers, activity, or post-translational modifications may 
help to explain the responses in EC and the role of hypoxia in this context. Furthermore, eNOS may play a critical 
role in β1 integrin-mediated regulation of FMD as well as in arteriogenesis and angiogenesis. Our current data 
show that β1 integrin knockdown decreases total and phosphorylated eNOS in vitro suggesting a potential func-
tional interaction. Previous literature showing that eNOS knockout mice have a phenotype with impaired FMD, 
arteriogenesis, and angiogenesis13,14 similar to the one of the mice we generated for the experiments described 
here. In face of the peripheral artery disease epidemic worldwide37 with essentially no specific pharmaceutical 
therapies available at hand38, a better understanding of the mechanisms underlying compensatory vascular main-
tenance and regeneration is essential to develop therapies in the future.
We conclude that β1 integrin is required for acute and chronic endothelium-dependent adaptations of the 
vasculature to HI. Furthermore, β1 integrin might act in concert with eNOS to induce FMD and is needed in 
vascular endothelial cells for arteriogenesis and angiogenesis following a permanent, chronic occlusion of the 
FA. Therefore, β1 integrin-mediated signalling events provide a framework for better understanding acute and 
chronic adaptation of the arterial vasculature to ischemia in the hindlimb.
Figure 4. Inhibition of flow-mediated dilation in endothelium-specific Itgb1 KO mice. (a + b) Flow velocity  
(a) over the first 150 s or (b) at 0 s during reperfusion after 5 min ischemia in Cre control mice and Itgb1iECKO 
mice (n = 5, per group). (c + d) Quantification of FMD over the first 150 s or (d) at 60 s during reperfusion after 
5 min ischemia in Cre control mice and Itgb1iECKO mice (n = 5, per group). All values are mean ± standard error 
of the mean (SEM), statistical significance was determined using unpaired two-tailed students t-test, *p ≤ 0.05.  
No statistical significances are shown in (a)(c).
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Methods
We have performed 4 sets of experiments (see Supplementary Fig. S1 for overview of study groups and proto-
cols). Study 1: In wild type C57BL/6 J mice (WT), we compared collateral expansion, de novo arteriogenesis, and 
angiogenesis in the thigh and calf after HI by FA ligation with sham operated animals. To investigate the role of β1 
integrin, we injected either a β1 integrin blocking antibody or control antibody in HI. Study 2: To study the role 
of endothelial β1 integrin, we compared arteriogenesis and angiogenesis (HI vs. sham) in mice with conditional 
endothelial cell specific deletion of β1 integrin (Itgb1iECKO) with Cre control mice (Control). Study 3: To investi-
gate the role of β1 integrin and eNOS in acute flow-dependent tone regulation of hindlimb conduit arteries, we 
compared microvascular flow velocity response and FMD in untreated WT mice with WT and eNOS knockout 
(NOS3−/−) animals that had either received a β1 integrin blocking antibody or isotype-control antibody. Study 4: 
To study the role of endothelial β1 integrin in acute arterial flow-dependent tone regulation, we compared micro-
vascular flow velocity response and FMD in mice with conditional endothelial cell specific deletion of β1 integrin 
(Itgb1iECKO) with Cre control mice (Control).
Mice. For all experiments 10 to 12 week old C57BL/6 J (Janvier) mice were used as well as global NOS3 knockouts39. 
Furthermore, for conditional endothelial cell specific deletion of Itgb1, Cdh5-CreERT2 mice40,41 were crossed with 
Itgb1-loxP mice (Itgb1iECKO)42. Cdh5-CreERT2 mice were used as controls with the same amount and frequency of 
tamoxifen injections. Knockout and control mice were intraperitoneally injected with 100 µl tamoxifen solution 
(75 mg/kg bw) for 5 days. All experiments were performed according to the German animal protection laws and 
the experimental protocols (project numbers: 84-02.04.2012.A404, 84-02.04.2014.A312, 84-02.04.2015.A241) 
were approved by the institutional licensing committee (Animal Ethics Committee of the Landesamt für Natur, 
Umwelt und Verbraucherschutz, North-Rhine-Westphalia, Germany).
Hindlimb ischemia protocol. The mice were anesthetized with ketamine (100 mg/kg) and xylazine (10 mg/
kg) intraperitoneal. The left FA was prepared carefully without damaging the vein and nerve and was ligated distal 
to the origin of the arteria profunda femoris with two sutures (Prolene 5/0, Ethicon). Between the two sutures the 
artery was cut. The wound was closed, and the animals were allowed to recover.
Laser-Doppler-Imaging for perfusion analysis. Before, immediately after or 3d post HI perfusion in 
thigh and calf were analysed45. Therefore, mice were anesthetized with 2.5–3.0 vol.-% isoflurane induction and 
1.5 vol.-% maintenance and placed on a 37 °C heating pad. For imaging both hindlimbs, operated and control one 
were scanned and perfusion rates were calculated on the basis of a color-coded histogram pixel.
Near infrared spectroscopy. For determination of oxygen levels in thigh and calf images with a near infra-
red spectroscopy (NIRS, Kent imaging), mice hindlimbs were imaged before, immediately after, and 7d post HI.
Injection of β1 integrin blocking antibody. The β1 integrin blocking antibody and the control antibody 
were injected intravenously two times per week at a concentration of 1 mg/ml (100 µl) into the mice starting preop-
eratively. The injections were performed in random order by a different person so that investigators were blinded to 
the treatment regime. The β1 integrin blocking antibody was a purified NA/LE hamster anti-rat CD29 (555002, BD 
Bioscience). A purified Armenian Hamster IgM Isotype control antibody (401006, Biolegend) was used as a control.
Immunostaining and cell death detection via TUNEL. On day 7 and 14 after surgery, mice were anes-
thetized with ketamine (100 mg/kg) and xylazine (10 mg/kg). Mice were euthanized and the left ventricle of the 
heart was cannulated and perfused for 2 minutes at 100 mmHg with Ringer solution containing 0.9% adenosine, 
0.1% sodium nitroprusside, and 0.05% BSA (wt/vol) at 37 °C followed by 4% paraformaldehyde. The thigh and 
calf muscles were dissected and immersed in 15% o.n. and 30% sucrose before cryo embedding.
Histological analyses were performed on transversal sections (12 µm) of the thigh and the calf of each 
mouse and fixed in 4% paraformaldehyde. Slides were blocked and stained with primary antibodies for rat 
anti-PECAM-1 antibody (550274, BD Bioscience) at 1/50 dilution or goat anti-PECAM-1 antibody (AF3628, 
R&D) at 1/20 dilution, primary mouse anti-SMA-Cy3 (C6198, Sigma Aldrich) at 1/100 dilution, primary rat 
anti-β1 integrin antibody (MAB1997, Millipore) at 1/200 dilution and primary rat anti-IgG2b (isotype-ctrl) 
antibody (ab18541, Abcam) at 1/100 dilution and incubated for 1 h at room temperature (RT) or over night at 
4 °C. Slides were then washed and secondary antibody conjugated with Alexa Fluor 488 (A32814 or A-21208, 
ThermoFischer Scientific), Cy3 (712-165-153, Jackson ImmunoResearch) and Cy5 (712-175-153, Jackson 
ImmunoResearch) was added at 1/500 dilution and incubated in the dark at RT for 1 h. Slides were mounted using 
Vectashield-DAPI mounting medium (Vector Laboratories) or DAPI was diluted 1/1,000 in secondary antibody 
incubation step. Random microscopic images from 2–3 different sections in each tissue block were examined for 
the presence of arterioles and capillaries. Pictures were acquired with a Nikon Eclipse Ti-S confocal microscope 
(Nikon), with an Axio Vert LSM710 confocal laser scan microscope (Zeiss) or Leica TCS SP8 STED3X (Leica). 
The capillary density was assessed relative to the number of muscle fibres and the arterioles numbers were calcu-
lated to area in mm2 using FIJI (Image J, National Institutes of Health). Apoptotic endothelial cells were detected 
via an in situ cell death detection kit (TUNEL) according to the manufacture’s instruction (12156792910, Roche). 
Co-staining of endothelial cells (PECAM-1) and cell nuclei (DAPI) was performed as described above.
LacZ staining. For analysis of KO efficiency, thighs from Itgb1iECKO and control mice were isolated and incu-
bated in 2% PFA over night at 4 °C. Thereafter, the tissue was stained in staining solution (5 mM potassium fer-
ricyanide, 5 mM potassium ferrocyanide, 2 mM magnesium chloride, 0.01% sodium deoxycholate and 0.02% 
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Nonidet P-40 diluted in PBS, pH 7.2–7.4). Directly before use, 25 μl of a 40 mg/ml X-Gal (5-brom-4-chloro-
3-indolyl β-D-galactopyranoside, B4252, Sigma Aldrich, diluted in dimethyl-formamide) stock solution was 
added to 1ml of staining solution. Thighs of Itgb1iECKO and control mice were incubated in staining solution over 
night at 37°C before imaging.
Visualization of collaterals using PU4 resin. On day 7 after FA ligation, mice were anesthetized with 
ketamine (100 mg/kg) and xylazine (10 mg/kg). Mice were euthanized and the aorta was cannulated and perfused 
for 2 min at 100 mmHg with Ringer solution containing 0.9% adenosine, 0.1% sodium nitroprusside, and 0.05% 
BSA (wt/vol) at 37 °C. Afterwards PU4ii resin and hardener (Vasqtec) were mixed and quickly injected. The hind-
limbs were digested with 1% Natriumhydroxide (AppliChem) and images were taken with a stereo microscope 
(Nikon SMZ1500). Measurements were performed by an observer blinded to sample allocation. The collateral 
arteries were measured at maximally 15 different random locations in every mouse.
Measurement of flow-mediated dilation in mice. The protocol was previously published2: Briefly, mice 
were anesthetized with isoflurane and the fur was removed from the hindlimbs. Then the animals were trans-
ferred to a warmed ultrasound investigation table equipped with ECG. A vascular occluder (5 mm diameter, 
Harvard Apparatus) was placed around the lower limb to induce occlusion of the distal hindlimb as an ischemic 
trigger. Pre-warmed ultrasound gel was applied to the proximal inner thigh, the ultrasound probe was manually 
aligned with visible blood vessels, and arterial blood flow in the FA confirmed by pulsed wave (PW) Doppler. 
The images of the FA were optimized to achieve clear contrast of the vessel walls. After recording baseline read-
ings, the vascular occlude was inflated manually with an air-filled syringe. Following 5 min of HI, the cuff was 
deflated and FA diameter and blood flow velocity measurements were recorded for 180 s at 30 s intervals. The 
recorded loops were analysed off-line by an operator blinded to group allocation using a semi-automated system 
(Brachial Analyzer, MIA) which is also used for human FMD analyses as described by Heiss et al.30. FMD was 
determined as ∆% in average FA diameter following reperfusion as compared to baseline pre-ischemic values: 
[(Diameterpost-ischemic – Diameterbaseline) ⁄ Diameterbaseline] * 100. All diameter readings were taken at end diastole.
To study the role of β1 integrin as a central mechanisms initiating FMD in mice (10–12 week old male), FMD 
was measured after β1 integrin blocking or control antibody injection (concentration described before) intrave-
nously in C57BL/6 J and age-matched eNOS knockout mice39. For dose-dependence analysis β1 integrin blocking 
antibodies were diluted 1/1,000 or 1/100. Furthermore, we tested FMD in mice with conditional endothelial cell 
specific deletion of Itgb1. Therefore, Cdh5-CreERT2 mice were crossed with Itgb1-loxP mice and results were 
compared to tamoxifen-injected Cdh5-CreERT2 control mice.
Magnetic-Activated Cell Sorting of endothelial cells and quantitative real-time PCR. To iso-
late EC from Itgb1iECKO and control mice hindlimbs, magnetic-activated cell sorting (MACS) was performed. 
Therefore, hindlimbs were dissociated with a gentleMACS Dissociator (Milteny Biotech). According to the man-
ufacture protocol a single-cell suspension was prepared and CD45 positive cells were depleted by labelling with 
‘CD45 MicroBeads’ (130-052-301, Milteny Biotech). CD45 positive cells, as leukocyte subtypes and platelets were 
depleted as they express PECAM-1 (CD31) as well, which was used in the next step for positive selection of EC. 
Following separation in magnetic field cell solution was labelled with ‘CD31 MicroBeads’ (130-097-418, Milteny 
Biotech) to finally isolate EC from hindlimbs.
To analyse β1 integrin expression in EC, cell pellets from MACS procedure were suspended in peqGold 
TriFast (PEQLAB) and total RNA was isolated by phenol/chloroform extraction43. RNA was transcribed in cDNA 
with SuperScript® II Reverse Transcriptase (Invitogen). Quantitative real-time PCR was completed by using 
Brilliant III Ultra-Fast SYBR® Green QPCR Master Mix and the thermal cycler Stratagene Mx3000P (Agilent 
Technologies). Samples were analyzed in duplicates. Primer sequences as followed:
mouse itgb1 forward: 5′-AATGCCAAGTGGGACACGGG-3′
mouse itgb1 reverse: 5′-TGACTAAGATGCTGCTGCTGTGAGC-3′
mouse β2m forward: 5′- GAGCCCAAGACCGTCTACTG-3′
mouse β2m reverse: 5′-GCTATTTCTTTCTGCGTGCAT-3′
Expression of endothelial β1 integrin was determined by means of 2^-ΔΔCt-value44 and therefore, β2m was 
used as housekeeping gene.
Primary human cell culture and transfection. Primary human coronary artery endothelial cells 
(HCAEC, male, 21 years old), purchased from PELOBiotech, were cultured in a humidified atmosphere at 5% 
CO2 and 37 °C using microvascular endothelial cell growth medium kit enhanced (PELOBiotech). HCAEC 
were grown up to passage 6. Cell culture dishes were pre-coated with speed coating solution (PELOBiotech). 
For knocking down the expression of β1 integrin, HCAEC were transfected with 250 nM ITGB1-siRNA 
(5′-CCUAAGUCAGCAGUAGGAACAUUAU-3′, Invitrogen) or a non-targeting control siRNA (Invitrogen) 
with a similar GC-content by electroporation (4D-NucleofectorTM System, LONZA) and incubated for 48 h. 
eNOS expression, phosphorylation, and β1 integrin knockdown efficiencies were analysed by Western blotting.
Western blotting. Cultured and transfected HCAEC were lysed in RIPA buffer (50 mM Tris/HCl pH 7.4, 
150 mM NaCl, 1% IGEPAL, 0.25% Na-deoxycholate, 1 mM EDTA) with protease inhibitors (cOmplete Protease 
Inhibitor Cocktail Tablets, Roche) and phosphatase inhibitors (Phosphatase Inhibitor Cocktail, Roche). After 
lysis, fresh samples were directly used for protein analysis. The lysates were heated in Laemmli buffer (Bio-Rad) 
containing β-mercaptoethanol (Roth) at 95 °C for 5 min. For SDS-PAGE, 4–15% SDS-gels (Bio-Rad) and 
Mini-PROTEAN Tetra Cell system (Bio-Rad) were used. The proteins were transferred to a PVDF membrane by 
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means of the Trans-Blot Turbo Transfer system (Bio-Rad). The membrane was incubated with rabbit anti-GAPDH 
(Abcam, ab9485) at 1/5,000 dilution, rabbit anti-eNOS (9572S, Cell Signaling Technologies) at 1/500 dilution, rabbit 
anti-Phospho(Ser1177)-eNOS (9571S, Cell Signaling Technologies) at 1/500 dilution or goat anti-β1 integrin 
(Santa Cruz, sc-6622) at 1/2,000 dilution as primary antibodies overnight at 4 °C, and HRP-conjugated donkey 
anti-rabbit (7074, Cell Signaling Technologies) at 1/2,000 dilution and donkey anti-goat (705-035-147, Jackson 
ImmunoResearch) at 1/5,000 dilution as secondary antibodies for 1 h at RT. Chemiluminescence was detected 
using WesternBright Quantum Kit (Advansta) and ChemiDoc MP Imaging System (Bio-Rad). For expression 
and phosphorylation evaluation, semi-quantitative band density analysis was performed in FIJI (ImageJ NIH), 
where GAPDH was used as housekeeping protein for normalization.
Statistical analyses. Statistical analyses were performed with Prism 6.0 for Mac OS X (GraphPad Software 
Inc.). All data are presented as mean ± standard error of the mean. Group differences were calculated with one- or 
two-way ANOVA and consecutive post hoc test (Tukey) or t-test if only 2 groups were compared. P-values less 
than or equal to 0.05 were regarded as significant.
Received: 28 January 2019; Accepted: 25 October 2019;
Published: xx xx xxxx
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